“…There is, however, significant topographic and phenotypic heterogeneity in hippocampal degeneration, creating difficulties in establishing strict criteria for widespread use. Moreover, hippocampal sclerosis is a pathological endpoint associated with various underlying disease processes, including epilepsy, hypoxia, hypoglycaemia, certain infections, and numerous neurodegenerative conditions (Josephs et al , 2007; Thom et al , 2009; Yokota et al , 2010; Malek-Ahmadi et al , 2013; Murray et al , 2013; Ling et al , 2017; Popkirov et al , 2017; Sen et al , 2018). Having originated in a 19th century study of epilepsy by Wilhelm Sommer (Sommer, 1880; Thom, 2009), the term hippocampal sclerosis is still used widely by radiologists and pathologists in the context of seizure disorders (Isnard and Bourdillon, 2015; Thom and Sisodiya, 2015).…”